Momentive Performance Materials Gmbh

Oncotherapy Science, Incorporated

David Jenkins

Aroop Kumar Roy

Julie Boyer

Yusuke Nakamura

Joel R Walker

Wenge Cui

Yo Matsuo

Helene Decornez

Shoji Hisada

Feryan Ahmed

Raymond Huntley

Robert Borbo Kargbo

Zohreh Sajjadi-Hashemi

Polivina Jolicia F Gauuan

Mahender Gurram

Kenrick M Lewis

Anantharaman Dhanabalan

Christopher Michael Byrne

Andrea Trotto

Mihirkumar Maheshbhai Patel

Juergen Koller

Indraneel Kundu

A process for cross-linking siloxane and organic polymers comprising reacting (a) a silyl hydride with (b) an unsaturated polymeric compound in the presence of (d) a platinum diene compound with a chelating dianionic ligand.

Platinum (II) diene complexes for controlled siloxane crosslinking

A process for the hydrosilylation of an unsaturated compound comprising reacting (a) a silyl hydride with (b) an unsaturated compound in the presence of (c) a platinum based hydrosilylation catalyst comprising a platinum-diene complex with chelating anions. The use of the present catalysts in the process provides silylated products in good yields and allows for using lower platinum loadings than conventional catalysts, reduced cycle times, and may reduce yellowing in the product.

Platinum (II) diene complexes with chelating dianionic ligands and their use in hydrosilylation reactions

The present invention provides curable compositions comprising non-tin metal accelerators that accelerate the condensation curing of moisture-curable silicones/non-silicones. In particular, the present invention provides an accelerator comprising amino acid compounds that are suitable as replacements for organotin in sealant and RTV formulations.

Moisture curable composition with amino acids

Tricyclic compounds are provided. These compounds are PBK inhibitors, and are useful for the treatment of PBK related diseases, including cancer.

Tricyclic compounds and PBK inhibitors containing the same

A process for the hydrosilylation of an unsaturated compound comprising reacting (a) a silyl hydride with (b) an unsaturated compound in the presence of (c) a platinum compound and (d) a cyclodiene, with the provisos that (i) when the unsaturated compound is a terminal alkyne, the silyl hydride is other than a halosilane, and (ii) when the platinum compound is a Pt(II)-based compound, the ratio of total moles of cyclodiene to moles of platinum is less than 3:1.

Platinum catalyzed hydrosilylation reactions utilizing cyclodiene additives

Growing community of inventors

Cohoes, NY, United States of America

David Jenkins